TriLink Biotechnologies said today that it has entered into a distribution agreement with Australia's Astral Scientific.
Terms of the agreement call for Astral to sell San Diego-based TrLink's modified nucleic acid products, including more than 150 modified nucleotides, custom oligonucleotides, and CleanAmp Hot Start PCR products.
Astral, based in the Sydney area, supplies the clinical diagnostics, life science research, and industrial markets.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
